Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1932 1
1937 1
1944 1
1950 1
1955 1
1958 2
1962 1
1963 3
1964 1
1967 2
1968 1
1970 1
1971 1
1973 3
1975 3
1976 1
1977 2
1978 9
1979 3
1980 3
1981 9
1982 7
1983 3
1984 9
1985 6
1986 13
1987 16
1988 17
1989 11
1990 14
1991 18
1992 17
1993 13
1994 14
1995 14
1996 12
1997 16
1998 15
1999 15
2000 11
2001 13
2002 14
2003 17
2004 22
2005 26
2006 28
2007 30
2008 20
2009 22
2010 41
2011 41
2012 42
2013 43
2014 45
2015 43
2016 69
2017 78
2018 87
2019 72
2020 65
2021 70
2022 77
2023 73
2024 73
2025 82
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,340 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean william s[au] (81 results)?
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, Litjens G, McKenney JK, Melamed J, Mottet N, Paner GP, Samaratunga H, Schoots IG, Simko JP, Tsuzuki T, Varma M, Warren AY, Wheeler TM, Williamson SR, Iczkowski KA; ISUP Grading Workshop Panel Members. van Leenders GJLH, et al. Among authors: williamson sr. Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497. Am J Surg Pathol. 2020. PMID: 32459716 Free PMC article.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Lawson M, Cureton N, Ros S, Cheraghchi-Bashi A, Urosevic J, D'Arcy S, Delpuech O, DuPont M, Fisher DI, Gangl ET, Lewis H, Trueman D, Wali N, Williamson SC, Moss J, Montaudon E, Derrien H, Marangoni E, Miragaia RJ, Gagrica S, Morentin-Gutierrez P, Moss TA, Maglennon G, Sutton D, Polanski R, Rosen A, Cairns J, Zhang P, Sánchez-Guixé M, Serra V, Critchlow SE, Scott JS, Lindemann JPO, Barry ST, Klinowska T, Morrow CJ, Carnevalli LS. Lawson M, et al. Among authors: williamson sc. Cancer Res. 2023 Dec 1;83(23):3989-4004. doi: 10.1158/0008-5472.CAN-23-0694. Cancer Res. 2023. PMID: 37725704 Free PMC article.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Gazeau N, Liang EC, Wu QV, Voutsinas JM, Barba P, Iacoboni G, Kwon M, Ortega JLR, López-Corral L, Hernani R, Ortiz-Maldonado V, Martínez-Cibrian N, Martinez AP, Maziarz RT, Williamson S, Nemecek ER, Shadman M, Cowan AJ, Green DJ, Kimble E, Hirayama AV, Maloney DG, Turtle CJ, Gauthier J. Gazeau N, et al. Among authors: williamson s. Transplant Cell Ther. 2023 Jul;29(7):430-437. doi: 10.1016/j.jtct.2023.04.001. Epub 2023 Apr 7. Transplant Cell Ther. 2023. PMID: 37031746 Free PMC article.
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. Trpkov K, et al. Among authors: williamson sr. Mod Pathol. 2021 Jul;34(7):1392-1424. doi: 10.1038/s41379-021-00779-w. Epub 2021 Mar 4. Mod Pathol. 2021. PMID: 33664427 Free article.
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.
Saeed A, Park R, Pathak H, Al-Bzour AN, Dai J, Phadnis M, Al-Rajabi R, Kasi A, Baranda J, Sun W, Williamson S, Chiu YC, Osmanbeyoglu HU, Madan R, Abushukair H, Mulvaney K, Godwin AK, Saeed A. Saeed A, et al. Among authors: williamson s. Nat Commun. 2024 Feb 20;15(1):1533. doi: 10.1038/s41467-024-45960-2. Nat Commun. 2024. PMID: 38378868 Free PMC article. Clinical Trial.
Staging of bladder cancer.
Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Magers MJ, et al. Among authors: williamson sr. Histopathology. 2019 Jan;74(1):112-134. doi: 10.1111/his.13734. Histopathology. 2019. PMID: 30565300 Review.
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Trpkov K, et al. Among authors: williamson sr. Mod Pathol. 2021 Jun;34(6):1167-1184. doi: 10.1038/s41379-021-00737-6. Epub 2021 Feb 1. Mod Pathol. 2021. PMID: 33526874 Free article.
Infantile Granular Parakeratosis.
Epstein S, Williamson S, Gelles L. Epstein S, et al. Among authors: williamson s. J Pediatr. 2025 May;280:114507. doi: 10.1016/j.jpeds.2025.114507. Epub 2025 Feb 12. J Pediatr. 2025. PMID: 39952392 Free article. No abstract available.
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.
Mittmann G, Laiouar-Pedari S, Mehrtens HA, Haggenmüller S, Bucher TC, Chanda T, Gaisa NT, Wagner M, Klamminger GG, Rau TT, Neppl C, Compérat EM, Gocht A, Haemmerle M, Rupp NJ, Westhoff J, Krücken I, Seidl M, Schürch CM, Bauer M, Solass W, Tam YC, Weber F, Grobholz R, Augustyniak J, Kalinski T, Hörner C, Mertz KD, Döring C, Erbersdobler A, Deubler G, Bremmer F, Sommer U, Brodhun M, Griffin J, Lenon MSL, Trpkov K, Cheng L, Chen F, Levi A, Cai G, Nguyen TQ, Amin A, Cimadamore A, Shabaik A, Manucha V, Ahmad N, Messias N, Sanguedolce F, Taheri D, Baraban E, Jia L, Shah RB, Siadat F, Swarbrick N, Park K, Hassan O, Sakhaie S, Downes MR, Miyamoto H, Williamson SR, Holland-Letz T, Wies C, Schneider CV, Kather JN, Tolkach Y, Brinker TJ. Mittmann G, et al. Among authors: williamson sr. Nat Commun. 2025 Oct 8;16(1):8959. doi: 10.1038/s41467-025-64712-4. Nat Commun. 2025. PMID: 41062516 Free PMC article.
1,340 results